Sentrin/small ubiquitin‐like modifier (SUMO) has emerged as a powerful mediator regulating biological processes and participating in pathophysiological processes that cause human diseases, such as cancer, myocardial fibrosis and neurological disorders. Here, SUMO1 is linked to nervous system disorder.